iHOP - Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes.

Find in this Page

Filter and options


Meneilly GS, Greig N, Tildesley H, Habener JF, Egan JM, Elahi D Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Diabetes Care (2003)
PMID: 14514588		Fulltext - Related articles - Download citation